by adminTorusBrand | Mar 1, 2017 | Axim Biotechnologies, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Press Releases
SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol...
by adminTorusBrand | Mar 1, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s...
by adminTorusBrand | Mar 1, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 28, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government approved a prescription for the Company’s...
by adminTorusBrand | Feb 21, 2017 | Company News, HempMeds Brasil
Medical Marijuana, Inc. portfolio company HempMeds® Brasil has shipped its flagship product, Real Scientific Hemp Oil™ (RSHO™), to a patient diagnosed with multiple sclerosis (MS). This is the first time that a patient in Brazil has successfully received import...
by adminTorusBrand | Feb 21, 2017 | Company News, HempMeds Brasil
Medical Marijuana, Inc. portfolio company HempMeds® Brasil has shipped its flagship product, Real Scientific Hemp Oil™ (RSHO™), to a patient diagnosed with multiple sclerosis (MS). This is the first time that a patient in Brazil has successfully received import...
by adminTorusBrand | Feb 21, 2017 | HempMeds Brasil, Press Releases
SAN DIEGO, Feb. 21, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the...